As of 2025-06-08, the Intrinsic Value of IND Swift Laboratories Ltd (INDSWFTLAB.NS) is 107.72 INR. This INDSWFTLAB.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 92.67 INR, the upside of IND Swift Laboratories Ltd is 16.20%.
The range of the Intrinsic Value is 103.49 - 113.77 INR
Based on its market price of 92.67 INR and our intrinsic valuation, IND Swift Laboratories Ltd (INDSWFTLAB.NS) is undervalued by 16.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 103.49 - 113.77 | 107.72 | 16.2% |
| DCF (Growth 10y) | 104.09 - 112.79 | 107.74 | 16.3% |
| DCF (EBITDA 5y) | 121.71 - 130.79 | 126.57 | 36.6% |
| DCF (EBITDA 10y) | 113.27 - 123.34 | 118.17 | 27.5% |
| Fair Value | 1,459.91 - 1,459.91 | 1,459.91 | 1,475.38% |
| P/E | 57.95 - 1,170.26 | 600.59 | 548.1% |
| EV/EBITDA | 125.59 - 252.16 | 189.32 | 104.3% |
| EPV | 255.35 - 298.86 | 277.11 | 199.0% |
| DDM - Stable | 211.40 - 389.51 | 300.46 | 224.2% |
| DDM - Multi | 14.56 - 21.21 | 17.29 | -81.3% |
| Market Cap (mil) | 5,617.66 |
| Beta | 1.43 |
| Outstanding shares (mil) | 60.62 |
| Enterprise Value (mil) | 1,397.07 |
| Market risk premium | 8.31% |
| Cost of Equity | 18.41% |
| Cost of Debt | 13.52% |
| WACC | 18.16% |